Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Slides:

Advertisements

Similar presentations

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Advertisements

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Long-term outcomes after revascularization for advanced popliteal artery entrapment syndrome with segmental arterial occlusion Seong-Yup Kim, MD, Seung-Kee.

Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease Mahmoud B. Malas, MD, MHS, Ngozi Enwerem, MBBS, Umair.

Prophylactic use of the silver-acetate–coated graft in arterial occlusive disease: A retrospective, comparative study Axel Larena-Avellaneda, MD, Sonja.

Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents Yiu Che Chan, MBBS, BSc, MD, FRCS, Stephen W.

Comparison of covered stents versus bare metal stents for treatment of chronic atherosclerotic mesenteric arterial disease Gustavo S. Oderich, MD, Luke.

Stenting of femoropopliteal lesions using interwoven nitinol stents

Role of simple and complex hybrid revascularization procedures for symptomatic lower extremity occlusive disease Hasan H. Dosluoglu, MD, Purandath Lall,

Endovascular treatment of long lesions of the superficial femoral artery: Results from a multicenter registry of a spiral, covered polytetrafluoroethylene.

Danielle B. Cameron, BA, James H. Black, MD, Elliot K

Drug-Coated Balloon Angioplasty Confers No Advantage in the Treatment of Femoropopliteal Disease When Stenting Is Required Brian Tiu, MD, Michael Shih,

Ali F. AbuRahma, MD, J. David Hayes, MD, Sarah K

Balloon angioplasty compared with stenting for treatment of femoropopliteal occlusive disease: A meta-analysis Bibombe Patrice Mwipatayi, MMed (Surg),

Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal interventions Andrew M. Bakken, MD, Eugene Palchik, MD, Joseph P. Hart,

Adjunctive use of the superficial femoral vein for vascular reconstructions Soma Brahmanandam, MD, MPH, Daniel Clair, MD, James Bena, MS, Timur Sarac,

Endovascular management of iliac artery occlusions: extending treatment to TransAtlantic Inter-Society Consensus class C and D patients Christopher D.

Blake A. Hamby, MD, Daniel E. Ramirez, MD, George E

Endovascular native vessel recanalization to maintain limb perfusion after infected prosthetic vascular graft excision Victor Z. Erzurum, MD, Dan Clair,

Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self- expanding stent graft versus prosthetic femoral-popliteal bypass in the.

Remote endarterectomy: Lessons learned after more than 100 cases

Evolving treatment of popliteal artery aneurysms

Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent Bao-Ngoc Nguyen,

Miguel Montero-Baker, MD, Gregory J

Results of heparin-bonded ePTFE-covered stents for chronic occlusive superficial femoral artery disease Mare M.A. Lensvelt, MD, Wilbert M. Fritschy,

Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease Jean-Baptiste Ricco,

Derek de Grijs, MD, Pedro Teixeira, MD, Steven Katz, MD

Virendra I. Patel, MD, Mark F. Conrad, MD, Christopher J

Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery.

Amy N. Roach, BS, Sebastian Larion, MS, Sadaf S. Ahanchi, MD, Chad P

The number of patent tibial vessels does not influence primary patency after nitinol stenting of the femoral and popliteal arteries Jenny J. Lee, MD,

Outcomes of reinterventions after subintimal angioplasty

Optimal conduit choice in the absence of single-segment great saphenous vein for below-knee popliteal bypass James T. McPhee, MD, Neal R. Barshes, MD,

Drug-eluting balloons for femoropopliteal lesions show better performance in de novo stenosis or occlusion than in restenosis Monika Herten, PhD, Giovanni.

Infrainguinal cutting balloon angioplasty in de novo arterial lesions

The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé.

Safety and efficacy of antiplatelet/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease Brant W. Ullery,

Sadaf S. Ahanchi, MD, Christopher L. Stout, MD, Tyler J

Outcome of drug-eluting balloon angioplasty versus endarterectomy in common femoral artery occlusive disease Tzu-Ting Kuo, MD, Po-Lin Chen, MD, Chun-Yang.

Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients Andrew M. Bakken, MD, Clinton D. Protack,

Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: A propensity-matched.

A comparison of the outcomes of one-stage and two-stage brachiobasilic arteriovenous fistulas Georgios Vrakas, MD, MSc, Fatima Defigueiredo, Sam Turner,

Primary stenting of the superficial femoral and popliteal artery

Balloon angioplasty for revision of failing lower extremity bypass grafts Haitham Ali, MD, Ahmed Elbadawy, MD, Mahmoud Saleh, MD, Ayman Hasaballah, MD

Harry Spoelstra, MD, Filip Casselman, MD, Olivier Lesceu, MD

Balloon angioplasty vs nitinol stent placement in the treatment of venous anastomotic stenoses of hemodialysis grafts after surgical thrombectomy John.

Long-term results of combined common femoral endarterectomy and iliac stenting/stent grafting for occlusive disease Robert W. Chang, MD, Philip P. Goodney,

Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive.

Eric C. Scott, MD, Andre Biuckians, MD, MPH, Ryan E

Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease Hasan H.

Supra-aortic hybrid endovascular procedures for complex thoracic aortic disease: Single center early to midterm results Yiu Che Chan, BSc MB, BS, MD,

Manish Mehta, MD, MPH, Yi Zhou, MD, Philip S. K

Endovascular repair of an acute blunt popliteal artery injury

Gregory C. Schmieder, MD, Megan Carroll, BA, BS, Jean M. Panneton, MD

A comparison of the standard bolia technique versus subintimal recanalization plus Viabahn stent graft in the management of femoro-popliteal occlusions

Christopher L. Skelly, MD, Katherine Gallagher, BS, Ronald M

Preliminary results of the initial United States experience with the Supera woven nitinol stent in the popliteal artery Luis R. León, MD, RVT, Robert.

High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty

Efficacious use of nitinol stents in the femoral and popliteal arteries Todd R Vogel, MD, Larry E Shindelman, MD, Gary B Nackman, MD, Alan M Graham, MD

Femorofemoral bypass with femoral popliteal vein

The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: A 10-year experience Toshifumi Kudo, MD, PhD,

Results of second-time angioplasty and stenting for femoropopliteal occlusive disease and factors affecting outcomes William P. Robinson, MD, Louis L.

The treatment of disabling intermittent claudication in patients with superficial femoral artery occlusive disease—Decision analysis Brian Nolan, MD,

Endovascular interventions for TASC II D femoropopliteal lesions

Endovascular brachytherapy for renal artery in-stent restenosis

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Everolimus Drug-Eluting Stents Are Associated With Improved Outcomes for the Treatment of Infrainguinal Bypass Graft Stenoses Caitlin W. Hicks, MD, MS,

Thigh claudication due to profunda femoris artery occlusion

Scott M. Surowiec, MD, Mark G. Davies, MD, PhD, Shirley W

Presentation transcript:

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen W. Cheng, MBBS, MS, FRCS, Grace C. Cheung, MMedSc Journal of Vascular Surgery Volume 62, Issue 5, Pages 1201-1209 (November 2015) DOI: 10.1016/j.jvs.2015.05.030 Copyright © 2015 Society for Vascular Surgery Terms and Conditions

Fig 1 An angiogram shows (A) right popliteal artery stenosis with (B) angioplasty and (C) stenting. D, Anteroposterior and (E) lateral view plain radiographs show the Supera stent (IDEV Technologies, Inc/Abbott Laboratories, Inc, Webster, Tex). Journal of Vascular Surgery 2015 62, 1201-1209DOI: (10.1016/j.jvs.2015.05.030) Copyright © 2015 Society for Vascular Surgery Terms and Conditions

Fig 2 Kaplan-Meier curve shows overall primary patency rates, with error bars representing standard errors. Journal of Vascular Surgery 2015 62, 1201-1209DOI: (10.1016/j.jvs.2015.05.030) Copyright © 2015 Society for Vascular Surgery Terms and Conditions

Fig 3 The primary patency rate as analyzed by disease segment of the superficial femoral artery (SFA) or SFA with or without the popliteal artery. Journal of Vascular Surgery 2015 62, 1201-1209DOI: (10.1016/j.jvs.2015.05.030) Copyright © 2015 Society for Vascular Surgery Terms and Conditions

Fig 4 The primary patency rate as analyzed by indication of treatment for claudication vs critical ischemia/tissue loss. Journal of Vascular Surgery 2015 62, 1201-1209DOI: (10.1016/j.jvs.2015.05.030) Copyright © 2015 Society for Vascular Surgery Terms and Conditions

Fig 5 The primary patency rate as analyzed by patients who had 5-mm or 4-mm Supera stents (IDEV Technologies, Inc/Abbott Laboratories, Inc, Webster, Tex) implanted. Journal of Vascular Surgery 2015 62, 1201-1209DOI: (10.1016/j.jvs.2015.05.030) Copyright © 2015 Society for Vascular Surgery Terms and Conditions